BioForce Nanosciences Debt / Equity
Cos'è Debt / Equity di BioForce Nanosciences?
Debt / Equity di BioForce Nanosciences Holdings, Inc. è -1.00
Qual è la definizione di Debt / Equity?
Il rapporto debito è un rapporto finanziario che indica la proporzione relativa del patrimonio netto e del debito utilizzato per finanziare le attività di una società.
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Debt / Equity di aziende nel Consumer Staples settore su OTC rispetto a BioForce Nanosciences
Cosa fa BioForce Nanosciences?
BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. The company offers private label products with distributors and manufacturing providers. It sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, and mass merchandisers under the BioForce Eclipse brand, as well as through online and telemarketing. The company is based in Virginia Beach, Virginia.
Aziende con debt / equity simili a BioForce Nanosciences
- Sparta Commercial Services ha Debt / Equity di -1.00
- Guskin Gold ha Debt / Equity di -1.00
- Integrated Wellness Acquisition ha Debt / Equity di -1.00
- Sucrerie et Raffinerie de l'Afrique Centrale NV ha Debt / Equity di -1.00
- Cox & Kings Service ha Debt / Equity di -1.00
- Alberton Acquisition ha Debt / Equity di -1.00
- BioForce Nanosciences ha Debt / Equity di -1.00
- Idera Pharmaceuticals ha Debt / Equity di -1.00
- NUGL ha Debt / Equity di -0.97
- H-CYTE ha Debt / Equity di -0.97
- Techcom Inc ha Debt / Equity di -0.94
- Branded Legacy Inc ha Debt / Equity di -0.93
- ImageWare Systems ha Debt / Equity di -0.84